Omega Therapeutics, Inc.
OMGAQ
$0.055
$0.0122.22%
OTC PK
09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 30.38M | 45.85M | 60.03M | 73.43M | 89.30M |
Total Receivables | 963.00K | 753.00K | 1.21M | 6.99M | 1.43M |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | 6.65M | 8.35M | 8.74M | 8.74M | 10.62M |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | 966.00K | 1.11M | 911.00K | 734.00K | 546.00K |
Total Current Assets | 38.95M | 56.06M | 70.89M | 89.88M | 101.90M |
|
|||||
Total Current Assets | 38.95M | 56.06M | 70.89M | 89.88M | 101.90M |
Net Property, Plant & Equipment | 113.74M | 112.11M | 112.38M | 114.05M | 115.45M |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 31.00K | 51.00K | 415.00K | 435.00K | 460.00K |
Total Assets | 152.73M | 168.23M | 183.68M | 204.37M | 217.81M |
|
|||||
Total Accounts Payable | 1.43M | 1.72M | 1.58M | 1.62M | 2.40M |
Total Accrued Expenses | 4.95M | 3.94M | 4.79M | 8.21M | 7.82M |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 15.92M | 15.83M | 15.99M | 15.30M | 16.60M |
Total Finance Division Other Current Liabilities | 1.87M | 4.06M | 2.32M | 1.67M | -- |
Total Other Current Liabilities | 1.87M | 4.06M | 2.32M | 1.67M | -- |
Total Current Liabilities | 24.17M | 25.54M | 24.68M | 26.81M | 26.82M |
|
|||||
Total Current Liabilities | 24.17M | 25.54M | 24.68M | 26.81M | 26.82M |
Long-Term Debt | 11.59M | 12.91M | 13.90M | 14.89M | 15.86M |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | 100.63M | 98.21M | 97.73M | 98.24M | 98.75M |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | 4.80M | 5.30M | 6.02M | 6.42M | 340.00K |
Total Liabilities | 141.18M | 141.96M | 142.33M | 146.35M | 141.77M |
|
|||||
Common Stock & APIC | 399.06M | 397.33M | 396.12M | 392.66M | 390.55M |
Retained Earnings | -387.51M | -371.07M | -354.76M | -334.63M | -314.42M |
Treasury Stock & Other | -- | -- | -- | -14.00K | -86.00K |
Total Common Equity | 11.54M | 26.26M | 41.35M | 58.02M | 76.04M |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 11.54M | 26.26M | 41.35M | 58.02M | 76.04M |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 11.54M | 26.26M | 41.35M | 58.02M | 76.04M |
|